Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
8 Leser
Artikel bewerten:
(0)

ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2010 Results

SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- RESMED INC. , announced today that on Thursday, August 5, 2010, it will release its results for the fourth quarter and fiscal year ended June 30, 2010. A press release with ResMed's results will be issued after 1:00 p.m. Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

The conference call is scheduled to begin at 1:30 p.m. Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com/. Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q4 2010 results webcast." The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be: 9:30 p.m. London 6:30 a.m. Sydney, Australia (August 6, 2010) TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator: US: 800-299-8538 Outside US: 617-786-2902 Q4 2010 ResMed Inc. Results Conference Name: Conference Call Participant Passcode: 86087175 The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at: US: 888-286-8010 Outside US : 617-801-6888 Passcode: 89978676

ResMed is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing and other respiratory disorders. Further information can be obtained by contacting Constance Bienfait at ResMed Inc. at +1 (858) 836-5971, or by visiting the Company's Web site at http://www.resmed.com/.

ResMed Inc.

CONTACT: Constance Bienfait of ResMed Inc., +1-858-836-5971

Web Site: http://www.resmed.com/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.